Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing risk in smokers.

J Lee Westmaas1, Thomas H Brandon

  • 1Department of Psychology, University at Stony Brook, State University of New York, Stony Brook, New York 11794-2500, USA. Johann.Westmaas@sunysb.edu

Current Opinion in Pulmonary Medicine
|June 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare contact days in cancer survivors relative to those with no cancer history.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Mobile App-Based Smoking Cessation in Hispanic or Latino Adults: Culturally Tailored Spanish-Language Formative App Development Study.

JMIR formative research·2026
Same author

Associations of smoking with the risk of second smoking-associated primary cancer among adults with a history of cancer.

Cancer epidemiology·2026
Same author

Understanding the Sources of Subnational Disparities in Cigarette Smoking Prevalence: Findings From a Multi-State Rapid-Response Survey in the U.S., 2023-2024.

American journal of preventive medicine·2026
Same author

Intended Behaviors in Anticipation of a National Menthol Flavor Ban: Findings From a Multi-State Rapid-Response Survey in the U.S., 2023-2024.

American journal of preventive medicine·2026
Same author

Mitigating Tobacco-Related Disparities: A Subnational View of Tobacco Use Behaviors and Tobacco Control in High-Tobacco-Burden U.S. States.

American journal of preventive medicine·2026
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Quitting smoking significantly reduces health risks like lung cancer, even if full risk reversal takes decades. Combining pharmacotherapy with behavioral support offers the most effective strategies for successful smoking cessation.

Area of Science:

  • Public Health
  • Addiction Medicine
  • Respiratory Medicine

Background:

  • Tobacco smoking is a primary cause of lung cancer and COPD.
  • Nicotine replacement therapy (NRT) and bupropion are common smoking cessation aids.
  • Uncertainty exists regarding risk reduction from quitting, NRT's OTC status, and new tobacco product safety.

Purpose of the Study:

  • Review current evidence on smoking interventions.
  • Evaluate risk reduction associated with smoking cessation.
  • Assess the efficacy and safety of various cessation methods and products.

Main Methods:

  • Literature review of current evidence on smoking cessation.
  • Analysis of pharmacotherapy effectiveness (NRT, bupropion).
  • Evaluation of modified tobacco products and behavioral interventions.

Related Experiment Videos

Main Results:

  • Quitting smoking, at any point, substantially reduces health risks compared to continued smoking.
  • Bupropion and NRT double quit rates but NRT is often used improperly.
  • Modified tobacco products require more research; "low tar" cigarettes are ineffective for risk reduction.

Conclusions:

  • Healthcare providers should strongly encourage smoking cessation, highlighting pharmacotherapy.
  • Educating patients on proper pharmacotherapy use and providing follow-up support is crucial.
  • Effective cessation strategies involve combined behavioral and pharmacologic approaches.